Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016)
Fulgent Genetics' (FLGT) quarterly Cash from Discontinued Operations came in at 14000.0 in Q2 2016, up 17.65% quarter-over-quarter from 17000.0 in Q1 2016.
Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends
Fulgent Genetics has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 14000.0 for Q2 2016.
- Cash from Discontinued Operations for Q2 2016 came in at 14000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was 31000.0 (changed N/A YoY), and the FY2016 annual result was 31000.0, up 98.96% from the prior year.
- Cash from Discontinued Operations came in at 14000.0 for Q2 2016 at Fulgent Genetics, up from 17000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 14000.0 in Q2 2016 to a low of 916000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Fulgent Genetics | 570.68 Mn | 288.72 Mn | 21.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -17,000.00 |
| Mar 31, 2016 | -17,000.00 |
| Dec 31, 2015 | -916,000.00 |
| Dec 31, 2015 | -916,000.00 |